A carregar...

Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer

Immunosignaturing shows promise as a general approach to diagnosis. It has been shown to detect immunological signs of infection early during the course of disease and to distinguish Alzheimer’s disease from healthy controls. Here we test whether immunosignatures correspond to clinical classificatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hughes, Alexa K., Cichacz, Zbigniew, Scheck, Adrienne, Coons, Stephen W., Johnston, Stephen Albert, Stafford, Phillip
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397978/
https://ncbi.nlm.nih.gov/pubmed/22815729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0040201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!